Claire D. Advokat, Joseph Comaty, Robert Julien

Broschiertes Buch

Julien's Primer of Drug Action

Beschreibung

Julien's Primer of Drug Action continues to evolve side by side with the field it covers providing a thoroughly up to date look at psychotherapeutic and recreational drugs, including the latest research and the newest formulations. The thoroughly updated 14th edition features: * New coverage of opioids of abuse, and drugs used to treat of opioid dependence and opioid overdose * New research on the use of marijuana to treat Alzheimers, PTSD, and Epilepsy * New coverage of pharmacological, physiological, and psychoactive effects of synthetic marijuana including its toxicity * New research on Cannabidiol (CBD) and its therapeutic uses * New research of the efficacy of antipsychotics to treat dementia, Parkinson's, bipolar, OCD, and PTSD * The use of genetic testing to predict effectiveness of antidepressant treatment * New research on the use of ketamine for the treatment of depression

Autor

Claire Advokat received her Ph.D. in physiological psychology from Rutgers University. Her research area is psychopharmacology, specifically drugs used in the treatment of psychiatric and behavioral disorders. She has published over 80 articles, and received funding for her studies from the National Institute of Drug Abuse (NIDA), the Spencer Foundation, the Board of Regents of Louisiana, the State of Louisiana, and the pharmaceutical firm NPS. She received a university teaching award in 2005, served as an ad hoc reviewer for 20 journals, and serves on the editorial board of The Journal of Attention Disorders.

Produktdetails

• Verlag: Macmillan Learning
• Artikelnr. des Verlages: 978-1-319-24894-9
• 14th edition 2019
• Seitenzahl: 672
• Erscheinungstermin: 27. Juli 2018
• Englisch
• Abmessung: 231mm x 187mm x 27mm
• Gewicht: 1014g
• ISBN-13: 9781319248949
• ISBN-10: 1319248942
• Artikelnr.: 53532115